Clinical use of biomarkers in neurodegenerative disorders

The prevalence of neurodegenerative disorders is increasing dramatically and one of the major challenges today is the need of early and accurate diagnosis, the other is the need of more effective therapies -in turn the development of such therapies also requires early and accurate diagnosis-. The ma...

Descrición completa

Detalles Bibliográficos

Autor Principal:	Manuel Menendez-Gonzalez
Formato:	Online
Idioma:	inglés
Publicado:	Frontiers Media SA 2021
Subjects:	RC321-571 Q1-390 Neurodegenerative Diseases neurodegenerative disease Parkinson's disease MTAi biomarker Huntington's disease CSF biomarkers Frontotemporal dementia (FTD) thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences
Acceso en liña:	17793
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!